US Stock MarketDetailed Quotes

BMEZ Blackrock Health Sciences Trust II

Watchlist
  • 14.740
  • +0.100+0.68%
Close Dec 20 16:00 ET
  • 14.740
  • 0.0000.00%
Post 20:01 ET
1.53BMarket Cap-92.13P/E (TTM)

Blackrock Health Sciences Trust II Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q2)Jun 30, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q2)Jun 30, 2021
Assets
Cash cash equivalents and federal funds sold
-56.49%16.14K
1,165.87%457.17K
1,165.87%457.17K
-69.79%37.1K
-76.83%36.12K
-76.83%36.12K
-90.03%122.81K
-87.67%155.88K
-87.67%155.88K
-65.91%1.23M
-Cash and cash equivalents
-87.12%141
915.65%1.17K
915.65%1.17K
-98.74%1.1K
-99.90%115
-99.90%115
12,126.76%86.81K
11,828.66%119.88K
11,828.66%119.88K
-99.66%710
-Restricted cash and investments
-55.56%16K
1,166.67%456K
1,166.67%456K
0.00%36K
0.00%36K
0.00%36K
-97.08%36K
-97.15%36K
-97.15%36K
-63.80%1.23M
Receivables
-86.94%2.33M
46.84%1.48M
46.84%1.48M
1,349.83%17.87M
-34.01%1.01M
-34.01%1.01M
-75.69%1.23M
18.44%1.53M
18.44%1.53M
-62.01%5.07M
Prepaid assets
--20.5K
--16.16K
--16.16K
----
----
----
--0
139.26%48.37K
139.26%48.37K
----
-Available for sale securities
--105.23M
----
----
----
----
----
----
----
----
----
Derivative assets
----
-71.21%1.43M
-71.21%1.43M
--963.12K
--4.96M
--4.96M
----
----
----
----
Deferred costs
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-10.77%1.92B
-6.32%1.95B
-6.32%1.95B
0.12%2.15B
-30.89%2.09B
-30.89%2.09B
-38.18%2.15B
-14.84%3.02B
-14.84%3.02B
29.19%3.48B
Liabilities
Payables
-84.55%5.74M
-70.32%2.61M
-70.32%2.61M
527.39%37.16M
8.51%8.79M
8.51%8.79M
-29.42%5.92M
-62.61%8.1M
-62.61%8.1M
49.32%8.39M
-Accounts payable
-92.56%2.27M
----
----
882.03%30.54M
-37.23%2.9M
-37.23%2.9M
-5.26%3.11M
-74.39%4.62M
-74.39%4.62M
36.25%3.28M
-Other payable
-47.55%3.47M
-55.69%2.61M
-55.69%2.61M
135.24%6.62M
69.30%5.89M
69.30%5.89M
-44.94%2.81M
-3.77%3.48M
-3.77%3.48M
59.13%5.11M
Long term debt and capital lease obligation
--18.9K
206.23%291.88K
206.23%291.88K
----
--95.31K
--95.31K
-95.52%69.8K
----
----
--1.56M
Derivative product liabilities
-11.44%17.85M
69.94%31.43M
69.94%31.43M
2.23%20.15M
-20.09%18.5M
-20.09%18.5M
-46.54%19.71M
-53.47%23.15M
-53.47%23.15M
-4.07%36.88M
Other liabilities
-25.06%29.18M
572.17%12.3M
572.17%12.3M
467.74%38.94M
-62.96%1.83M
-62.96%1.83M
9.82%6.86M
-48.42%4.94M
-48.42%4.94M
230.49%6.25M
Total liabilities
-45.11%52.89M
58.83%46.7M
58.83%46.7M
193.66%96.35M
-19.19%29.4M
-19.19%29.4M
-38.98%32.81M
-55.43%36.38M
-55.43%36.38M
16.13%53.77M
Shareholders'equity
Share capital
-9.35%1.95B
-10.41%1.95B
-10.41%1.95B
-4.08%2.15B
-3.36%2.18B
-3.36%2.18B
-0.42%2.24B
0.00%2.25B
0.00%2.25B
0.00%2.25B
-common stock
-9.35%1.95B
-10.41%1.95B
-10.41%1.95B
-4.08%2.15B
-3.36%2.18B
-3.36%2.18B
-0.42%2.24B
0.00%2.25B
0.00%2.25B
0.00%2.25B
Retained earnings
13.38%-81.07M
63.99%-43.69M
63.99%-43.69M
24.71%-93.6M
-116.65%-121.32M
-116.65%-121.32M
-110.58%-124.32M
-39.76%728.49M
-39.76%728.49M
197.03%1.17B
Total stockholders'equity
-9.16%1.87B
-7.25%1.91B
-7.25%1.91B
-2.88%2.06B
-31.04%2.06B
-31.04%2.06B
-38.17%2.12B
-13.88%2.98B
-13.88%2.98B
29.42%3.43B
Total equity
-9.16%1.87B
-7.25%1.91B
-7.25%1.91B
-2.88%2.06B
-31.04%2.06B
-31.04%2.06B
-38.17%2.12B
-13.88%2.98B
-13.88%2.98B
29.42%3.43B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q2)Jun 30, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q2)Jun 30, 2021
Assets
Cash cash equivalents and federal funds sold -56.49%16.14K1,165.87%457.17K1,165.87%457.17K-69.79%37.1K-76.83%36.12K-76.83%36.12K-90.03%122.81K-87.67%155.88K-87.67%155.88K-65.91%1.23M
-Cash and cash equivalents -87.12%141915.65%1.17K915.65%1.17K-98.74%1.1K-99.90%115-99.90%11512,126.76%86.81K11,828.66%119.88K11,828.66%119.88K-99.66%710
-Restricted cash and investments -55.56%16K1,166.67%456K1,166.67%456K0.00%36K0.00%36K0.00%36K-97.08%36K-97.15%36K-97.15%36K-63.80%1.23M
Receivables -86.94%2.33M46.84%1.48M46.84%1.48M1,349.83%17.87M-34.01%1.01M-34.01%1.01M-75.69%1.23M18.44%1.53M18.44%1.53M-62.01%5.07M
Prepaid assets --20.5K--16.16K--16.16K--------------0139.26%48.37K139.26%48.37K----
-Available for sale securities --105.23M------------------------------------
Derivative assets -----71.21%1.43M-71.21%1.43M--963.12K--4.96M--4.96M----------------
Deferred costs --0--0--0--0--0--0--0--0--0--0
Total assets -10.77%1.92B-6.32%1.95B-6.32%1.95B0.12%2.15B-30.89%2.09B-30.89%2.09B-38.18%2.15B-14.84%3.02B-14.84%3.02B29.19%3.48B
Liabilities
Payables -84.55%5.74M-70.32%2.61M-70.32%2.61M527.39%37.16M8.51%8.79M8.51%8.79M-29.42%5.92M-62.61%8.1M-62.61%8.1M49.32%8.39M
-Accounts payable -92.56%2.27M--------882.03%30.54M-37.23%2.9M-37.23%2.9M-5.26%3.11M-74.39%4.62M-74.39%4.62M36.25%3.28M
-Other payable -47.55%3.47M-55.69%2.61M-55.69%2.61M135.24%6.62M69.30%5.89M69.30%5.89M-44.94%2.81M-3.77%3.48M-3.77%3.48M59.13%5.11M
Long term debt and capital lease obligation --18.9K206.23%291.88K206.23%291.88K------95.31K--95.31K-95.52%69.8K----------1.56M
Derivative product liabilities -11.44%17.85M69.94%31.43M69.94%31.43M2.23%20.15M-20.09%18.5M-20.09%18.5M-46.54%19.71M-53.47%23.15M-53.47%23.15M-4.07%36.88M
Other liabilities -25.06%29.18M572.17%12.3M572.17%12.3M467.74%38.94M-62.96%1.83M-62.96%1.83M9.82%6.86M-48.42%4.94M-48.42%4.94M230.49%6.25M
Total liabilities -45.11%52.89M58.83%46.7M58.83%46.7M193.66%96.35M-19.19%29.4M-19.19%29.4M-38.98%32.81M-55.43%36.38M-55.43%36.38M16.13%53.77M
Shareholders'equity
Share capital -9.35%1.95B-10.41%1.95B-10.41%1.95B-4.08%2.15B-3.36%2.18B-3.36%2.18B-0.42%2.24B0.00%2.25B0.00%2.25B0.00%2.25B
-common stock -9.35%1.95B-10.41%1.95B-10.41%1.95B-4.08%2.15B-3.36%2.18B-3.36%2.18B-0.42%2.24B0.00%2.25B0.00%2.25B0.00%2.25B
Retained earnings 13.38%-81.07M63.99%-43.69M63.99%-43.69M24.71%-93.6M-116.65%-121.32M-116.65%-121.32M-110.58%-124.32M-39.76%728.49M-39.76%728.49M197.03%1.17B
Total stockholders'equity -9.16%1.87B-7.25%1.91B-7.25%1.91B-2.88%2.06B-31.04%2.06B-31.04%2.06B-38.17%2.12B-13.88%2.98B-13.88%2.98B29.42%3.43B
Total equity -9.16%1.87B-7.25%1.91B-7.25%1.91B-2.88%2.06B-31.04%2.06B-31.04%2.06B-38.17%2.12B-13.88%2.98B-13.88%2.98B29.42%3.43B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----Unqualified Opinion----Unqualified Opinion----
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List